ÂåÀøªÑ±a°Ê¤É¶Õ ¹D«ü´¿¯}23000ÂI
¡i©ú³ø±M°T¡j ¹D«ü©P¤Gº¦¸µu¼È½Ä¯}23,000ÂIÃö¤f¡A½Ä¦Ü³Ð¬ö¿ýªº23,002.20ÂI¡A¥Dn±o¯q©óÁp¦XÂåÀø«OÀI(UnitedHealth)»P±j¥Í¤½¥q(Johnson & Johnson)¦¬¯qªº«P°Ê¡A¤£¹L¦¬¥«²¤§C©ó¸Ó¤ô¥¡C¼Ð´¶500«ü¼Æªí²{¥¥¡A§ë¸êªÌ¹ï¤@¨Ç»È¦æ¤½¥¬ªº·~ÁZ¤ÏÀ³·L®z¡A¤£¹L¦¬¥««e²¤¦³¤W´¡C
¹D«ü¤µ¦~¤w¸g3¦¸¶W¶V¦¹«eªº1,000ÂI¤jÃö¡A¤@ª½¦béwÃk¤É¡A¥»¤ë¨´¤µ¼W´T2.6%¡A®Æ·|¿ý±o³sÄò²Ä7Ó¤ë¤É¶Õ¡C
¤£¹LBoston Private Wealth¤ÀªRû©¬§Q§J(Robert Pavlik)»¡¡A¥L¹wp¡A¹D«üªñ´Á®ÆÃø¦A¬ð¯}23,000ÂI¡C©¬§Q§J»¡¡G¡u§Ú¹wp¡A¥¦¦bºû«ù³oÓ¤ô¥¥H¤W¤§«e¡A·|¥ý¦^¸¨¡C¥i¯àn´X¤Ñ¡A©ÎªÌ¨â¡B¤T©P¡C¡v
Áp¦XÂåÀø«OÀI³ø§i±j©ó¹w´Áªº§Q¼í¡A½Õ°ª¥þ¦~¬Õ§Q¹w´ú¡AªÑ²¼¦¬¥«¤É5.5%¡C±j¥Í¤½¥q¦P¼Ë¤½¥¬³Ó¹L¤ÀªRû¹w´úªº·~ÁZ¡AªÑ²¼¤É3.4%¡A¤Þ»â¼Ð´¶500ÂåÀøªÑªº1.3%¤É´T¡C
§ë¸ê»È¦æ°ª²±(Goldman Sachs)©M¹ï¤â¼¯®Ú¤h¤¦§Q(Morgan Stanley)¤½¥¬²Ä¤T©u«×·~ÁZ¡A³£³Ó¹L¤ÀªRû¹w´Á¡A¦ý°ª²±ªÑ»ù¤U·Æ2.6%¡CIBM¦¬¥««áªÑ»ù¤W´4.9%¡A¦]¤½¥q¤½¥¬¶W¹w´Áªº¦¬¤J¡C¥¿±`¦¬½L®É¬qIBMªÑ»ù¦¬146.54¤¸¡A¶^0.2%¡C
¹D«ü¤É40.48ÂI¡A©Î0.18%¡A¦Ü22,997.44ÂI¡Q¼Ð´¶500«ü¼Æº¦1.72ÂI¡A©Î0.07%¡A¦Ü 2,559.36ÂI¡C¯Ç«ü¤U·Æ0.35ÂI¡A¶^0.01%¡A¦Ü6,623.66ÂI¡C
¥[®³¤j¥DnªÑ²¼«ü¼Æ¨ú±o·L´T¼Wªø¡AÃe¤Ú}«Å¥¬¦bCSeries«È¾÷·~°È¤W»PªÅ¤¤¤Ú¤h¶°¹Î¦X§@«á¡AªÑ»ù©P¤Göt¤É¡A¦¬¥«2.73¤¸¡A¤É37¥P¡A©Îªñ16%¡C¦h«ü¤É14.20ÂI¡A©Î0.09%¡A¦Ü15,816.90ÂI¡C